# FDA recall D-0023-2023

> **Exela Pharma Sciences LLC** · Class I · drug recall initiated 2022-10-04.

## Product

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.

## Reason for recall

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0023-2023
- **Recalling firm:** Exela Pharma Sciences LLC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-10-04
- **Report date:** 2022-11-02
- **Termination date:** 2025-10-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lenoir, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0023-2023

## Citation

> AI Analytics. FDA recall D-0023-2023. Retrieved 2026-06-05 from https://api.ai-analytics.org/recall/D-0023-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*